North America Influenza Vaccines Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Influenza Vaccines Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Influenza Vaccines Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Influenza Vaccines Market Regional Analysis

6.2 North America Influenza Vaccines Market Revenue 2020-2028 (US$ Million)

6.3 North America Influenza Vaccines Market Forecast Analysis

7. North America Influenza Vaccines Market Analysis – by Vaccine Type

7.1 Quadrivalent Vaccines

7.1.1 Overview
7.1.2 Quadrivalent Vaccines: North America Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Trivalent Vaccines

7.2.1 Overview
7.2.2 Trivalent Vaccines: North America Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. North America Influenza Vaccines Market Analysis – by Virus Type

8.1 Influenza Virus Type A

8.1.1 Overview
8.1.2 Influenza Virus Type A: North America Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Influenza Virus Type B

8.2.1 Overview
8.2.2 Influenza Virus Type B: North America Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. North America Influenza Vaccines Market Analysis – by Technology

9.1 Egg-based

9.1.1 Overview
9.1.2 Egg-based: North America Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Cell-based

9.2.1 Overview
9.2.2 Cell-based: North America Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. North America Influenza Vaccines Market Analysis – by Route of Administration

10.1 Injection

10.1.1 Overview
10.1.2 Injection: North America Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.2 Nasal Spray

10.2.1 Overview
10.2.2 Nasal Spray : North America Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)

11. North America Influenza Vaccines Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Influenza Vaccines Market Breakdown, by Key Country, 2023 and 2028 (%)
11.2.1.1 North America Influenza Vaccines Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 US: North America Influenza Vaccines Market Breakdown, by Vaccine Type
11.2.1.1.2 US: North America Influenza Vaccines Market Breakdown, by Virus Type
11.2.1.1.3 US: North America Influenza Vaccines Market Breakdown, by Technology
11.2.1.1.4 US: North America Influenza Vaccines Market Breakdown, by Route of Administration

11.2.1.2 Canada: North America Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Canada: North America Influenza Vaccines Market Breakdown, by Vaccine Type
11.2.1.2.2 Canada: North America Influenza Vaccines Market Breakdown, by Virus Type
11.2.1.2.3 Canada: North America Influenza Vaccines Market Breakdown, by Technology
11.2.1.2.4 Canada: North America Influenza Vaccines Market Breakdown, by Route of Administration

11.2.1.3 Mexico : North America Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 Mexico : North America Influenza Vaccines Market Breakdown, by Vaccine Type
11.2.1.3.2 Mexico : North America Influenza Vaccines Market Breakdown, by Virus Type
11.2.1.3.3 Mexico : North America Influenza Vaccines Market Breakdown, by Technology
11.2.1.3.4 Mexico : North America Influenza Vaccines Market Breakdown, by Route of Administration

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 AstraZeneca

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Emergent BioSolutions Inc.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 GlaxoSmithKline plc.

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Mitsubishi Chemical Group Corporation

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Moderna, Inc.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 MYLAN N.V.

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Sanofi

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 SEQIRUS

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Serum Institute of India Pvt. Ltd

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Influenza Vaccines Market

Analysis By Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), and Route of Administration (Injection and Nasal Spray)